TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells by Aguiar Alpizar, Yeranddy et al.
ARTICLE
TRPV4 activation triggers protective responses to
bacterial lipopolysaccharides in airway epithelial
cells
Yeranddy A. Alpizar1,2, Brett Boonen1,2, Alicia Sanchez1,2, Carole Jung3, Alejandro López-Requena1,2,
Robbe Naert1,2, Brecht Steelant4, Katrien Luyts5, Cristina Plata3, Vanessa De Vooght5,
Jeroen A.J. Vanoirbeek 5, Victor M. Meseguer6, Thomas Voets1,2, Julio L. Alvarez1, Peter W. Hellings4,7,
Peter H.M. Hoet5, Benoit Nemery5, Miguel A. Valverde3 & Karel Talavera1,2
Lipopolysaccharides (LPS), the major components of the wall of gram-negative bacteria,
trigger powerful defensive responses in the airways via mechanisms thought to rely solely on
the Toll-like receptor 4 (TLR4) immune pathway. Here we show that airway epithelial cells
display an increase in intracellular Ca2+ concentration within seconds of LPS application. This
response occurs in a TLR4-independent manner, via activation of the transient receptor
potential vanilloid 4 cation channel (TRPV4). We found that TRPV4 mediates immediate
LPS-induced increases in ciliary beat frequency and the production of bactericidal nitric oxide.
Upon LPS challenge TRPV4-deﬁcient mice display exacerbated ventilatory changes and
recruitment of polymorphonuclear leukocytes into the airways. We conclude that LPS-
induced activation of TRPV4 triggers signaling mechanisms that operate faster and inde-
pendently from the canonical TLR4 immune pathway, leading to immediate protective
responses such as direct antimicrobial action, increase in airway clearance, and the regulation
of the inﬂammatory innate immune reaction.
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Epithelial cells (EC) lining the airways constitute the fore-front line of defense against inhaled pathogens. Coveredwith a mucociliary layer and connected by tight junction
proteins, EC serve as a structural barrier against inhaled patho-
gens, and control the screening of the luminal microenvironment
by antigen-presenting cells1. Furthermore, EC are endowed with
pathogen-recognition receptors such as Toll-like receptors (TLR),
which detect microbial motifs and initiate events leading to the
production of cytokines and recruitment of circulating leukocytes
to the airways2, 3. In addition to its role in innate immunity,
TLR4-dependent stimulation of EC has also been shown to
modulate the activation, maturation, and migration of mucosal
dendritic cells, thus playing a crucial role in antigen-speciﬁc
immunity4–6.
However, recent studies in sensory neurons showed that the
recognition of pathogen-derived cues is not restricted to the
classical immune-related receptors (e.g., TLRs, nucleotide-binding
oligomerization-domain-like receptor, protease-activated recep-
tors, and C-type lectin receptor). For instance, formylated peptides
and α-hemolysin derived from gram-positive bacteria7 and
lipopolysaccharides (LPS) from gram-negative bacteria8 directly
activate nociceptive neurons. This leads to action potential ﬁring
that may underlie infection-associated pain sensations7–10, and the
release of the calcitonin gene-related peptide, which is implicated
in neurogenic inﬂammation8 and the regulation of immune
responses7. Also airway ECs have been shown to detect molecules
secreted by gram-negative bacteria. Activation of bitter taste
receptors in these cells by bacterial quorum-sensing molecules
induces an increase of intracellular Ca2+ concentration, leading to
nitric oxide (NO) production, augmented mucociliary clearance,
and direct anti-bacterial effect11. Despite the crucial role of EC in
defensive responses of the airways, it is currently unknown whe-
ther these cells are equipped with mechanisms allowing for fast,
TLR-independent detection of bacterial endotoxins. We hypo-
thesized that, like sensory neurons, EC may be able to quickly
respond to acute stimulation with LPS through the activation of
Ca2+-permeable channels.
To test this, we determined the effects of LPS on intracellular
Ca2+ dynamics of airway EC. We found that LPS increases
intracellular Ca2+ concentration in mouse and human airway EC
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Fig. 1 LPS stimulates mTEC in a TLR4-independent and TRPV4-dependent manner. a, b Effects of LPS (20 µg ml−1), GSK1016790A (10 nM) and ATP (20
µM) on the intracellular Ca2+ concentration in mTEC primary cultures from wild type (a) or Tlr4 KO (b). c Traces of intracellular Ca2+ concentration
showing the lack of response of mTEC to the TRPA1 agonist cinnamaldehyde (CA, 300 μM) and to the TRPV1 agonist capsaicin (1 μM). d mRNA
expression proﬁle of several TRP genes. Data is shown as 2−ΔΔCT relative to Trpm7 expression. e Average amplitudes of intracellular Ca2+ responses to LPS
(20 μg ml−1), the TRPA1 agonist cinnamaldehyde (CA, 300 μM), and the TRPV1 agonist capsaicin (Caps, 1 μM) in cells responsive or irresponsive to 10 nM
GSK1016790A. n= 73; *P< 0.05, Mann–Whitney U test. f Effects of LPS (20 µg ml−1), GSK1016790A (10 nM) and ATP (20 µM) on the intracellular Ca2+
concentration in mTEC primary cultured from Trpv4 KO mice. g, h Traces of intracellular Ca2+ concentration in wild type (g) and Tlr4 KO (h) cells exposed
to 10 µM HC067047, 20 µg ml−1 LPS and later on to 10 nM GSK1016790A (GSK). i Percentage of mTEC responding to LPS (n> 46). **P< 0.01, Fisher’s
exact test. HC, HC067047 (10 µM)
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within seconds of application, via a mechanism that does not
require TLR4, but the activation of the transient receptor
potential (TRP) cation channel TRPV4. Furthermore, activation
of TRPV4 by LPS triggers an increase in ciliary beat frequency
(CBF) and an immediate release of NO, a compound that
exerts direct antimicrobial and bronchodilation actions and
that regulates neutrophil inﬁltration into the airways. In line with
these results, the inhibition of TRPV4, either pharmacologically
or genetically, results in enhanced ventilatory and inﬂammatory
responses to LPS challenge in mice. Our data thus unveil TRPV4
as a key player in innate defense responses to bacterial endotoxins
and argue against therapeutic inhibition of this channel in con-
ditions associated with respiratory infections with gram-negative
bacteria.
Results
TRPV4 mediates Ca2+ responses to LPS in airway EC. We used
intracellular Ca2+ imaging to determine whether LPS acutely
stimulates freshly isolated mouse tracheobronchial ECs (mTEC).
We found an increase in intracellular Ca2+ concentration in ~
50% of the cells isolated from wild-type (WT) mice (Fig. 1a, i).
Surprisingly, the prevalence of the responses was similar in cells
isolated from Tlr4 knockout (KO) mice (Fig. 1b, i), demonstrating
a lack of requirement of TLR4-dependent signaling. The
responses to LPS were virtually absent when Ca2+ was omitted in
the extracellular solution (Supplementary Fig. 1a, b), indicating
that they were primarily produced by Ca2+ inﬂux through the
plasma membrane. LPS-induced responses were not mediated by
either TRPA1 or TRPV1, two cation channels implicated in LPS
effects in sensory neurons8–10, 12, since we did not detect func-
tional expression of these channels in mTEC (Fig. 1c–e). The
responses to LPS occurred mainly in cells responding to the
TRPV4 agonist GSK1016790A (Fig. 1e), suggesting an implica-
tion of this channel. Consistent with this idea, cells isolated from
Trpv4 KO mice were largely unresponsive to LPS and totally
insensitive to GSK1016790A, but displayed normal responses to
ATP (Fig. 1f, i). Furthermore, responses to LPS were drastically
reduced in WT and Tlr4 KO cells pre-incubated with the TRPV4
inhibitor HC067047 (Fig. 1g–i). Taken together, these data
indicate that LPS induces Ca2+ entry through TRPV4 channels in
mTEC.
LPS activates TRPV4. To determine whether LPS activates
TRPV4 channels we performed patch-clamp experiments in
HEK293T cells transiently transfected with mouse TRPV4.
Extracellular application of this compound elicited a fast and
reversible increase in the amplitude of currents (Fig. 2a). Currents
elicited by LPS showed typical features of TRPV4 activation, as
their reversal potential and rectiﬁcation pattern were similar to
those of the currents activated by GSK1016790A (Fig. 2b–d). LPS
was largely ineffective when applied in the presence of the TRPV4
antagonist HC067047 (Fig. 2e).
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Fig. 2 LPS activates TRPV4. a Example of the effects of LPS on the amplitude of currents measured at +100 and −100mV in a HEK293T cell transfected
with mTRPV4. The colored data points correspond to the traces shown in (b). b Top, currents recorded in control (black trace) or in the presence of LPS
(20 µg ml−1, red trace). The purple trace represents the difference of the red and black traces, i.e., the current induced by LPS. Bottom, comparison of the
currents induced by LPS and GSK1016790A (10 nM, blue trace). The green trace represents the GSK1016790A-evoked current normalized to the
amplitude of the LPS-evoked current measured at +100mV. c, d Average reversal potential (c) and rectiﬁcation index (d) of currents induced by
application of LPS or GSK1016790A (n= 11). e Average change of current amplitudes induced by the application of 20 µgml−1 LPS (n= 11) or 20 µg ml−1
LPS in the presence of 10 µM HC067047 (n= 7). # represents the comparison to ΔCurrent= 0 pA. #P< 0.05; ##P< 0.01 (n= 6), one sample t-test. *P<
0.05;
**P< 0.01 (n= 6), two-tailed t-test
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As found in mTEC, LPS induced a robust increase in
intracellular Ca2+ concentration in HEK293T cells heterologously
expressing mouse TRPV4 (sensitive to GSK1016790A; Fig. 3a).
This effect was concentration-dependent, with an effective
concentration (EC50) of 11.0± 0.7 µg ml−1 and a Hill coefﬁcient
of 2.9± 0.4 (Fig. 3b). HEK293T cells not expressing TRPV4
(unresponsive to GSK1016790A) were virtually insensitive to LPS
(Fig. 3a, b). LPS-induced responses in TRPV4-expressing cells
were fully absent when Ca2+ was omitted in the extracellular
solution (Supplementary Fig. 2a, b) and strongly reduced by
HC067047 (Supplementary Fig. 2c). Taken together, the patch-
clamp and Ca2+ imaging data demonstrate that LPS can induce
Ca2+ entry via the activation of TRPV4 channels.
Next, we wanted to conﬁrm that the canonical TLR4 pathway
is not required for the activation of TRPV4 by LPS. Pre-
incubation with the TLR4 inhibitor Cli-095 did not affect the
response of TRPV4-expressing cells to LPS (Fig. 3c, f) and had a
marginal inhibitory effect on the response to GSK1016790A
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Fig. 3 LPS activates TRPV4 in a TLR4-independent manner. a Intracellular Ca2+ signals in HEK293T cells overexpressing mouse TRPV4. The black and blue
traces correspond to GSK1016790A-sensitive cells responding or not to 20 μg ml−1 of LPS, respectively. The red traces correspond to non-transfected cells
(GSK1016790A-insensitive). b Concentration dependence of the amplitude of LPS-induced intracellular Ca2+ responses (n> 100 per data point). The solid
line represents the ﬁt of the data obtained in GSK1016790A-positive cells with a Hill equation. The red symbols correspond to GSK1016790A-insensitive
cells. c Intracellular Ca2+ signals recorded in HEK293T cells pre-incubated with the TLR4 antagonist Cli-095 (1 μM). d Intracellular Ca2+ signals recorded in
HEK293T cells treated with LPS pre-incubated with Polymixin B (PMB, 300 μg ml−1). In c, d, the black and red traces represent TRPV4-transfected and
non-transfected cells, respectively. LPS 20 µgml−1 and GSK1016790A (GSK) 10 nM. e Intracellular Ca2+ signals in response to Salmonella minnesota LPS
(20 μg ml−1). f Average amplitude of the intracellular Ca2+ responses to 20 μg ml−1 LPS from E. coli and S. minnesota, and to E. coli LPS in the presence of the
TLR4 inhibitor Cli-095 (1 µM, n= 77) or the LPS scavenger Polymyxin B (PMB, 300 µg ml−1, n= 32). **P≤ 0.01, two-tailed Kruskal–Wallis. g Average
amplitudes of the responses to GSK1016790A (GSK) alone or mixed with Cli-095 or PMB in TRPV4-transfected HEK293T cells (n> 30 per bar). *P< 0.05,
Dunn’s multiple comparison test
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(Fig. 3c, g). On the other hand, co-application of Polymyxin B
(PMB), an LPS scavenger that binds to the lipid A moiety,
strongly reduced the responses to LPS (Fig. 3d, f), but did not
affect the response to GSK1016790A (Fig. 3d, g). Hence, LPS can
activate TRPV4 independently of TLR4, and the lipid A moiety of
LPS is required to be freely available for channel activation. We
found that LPS extracted from Salmonella minnesota is also
capable of activating TRPV4 (Fig. 3e, f), indicating that, unlike for
TRPA18–10, the shape of lipid A moeity is not determinant in the
stimulation of TRPV4. In the following we explored the cellular
and systemic consequences of LPS-induced activation of TRPV4
in airway ECs.
LPS-induced activation of TRPV4 triggers NO production.
Upon stimulation with LPS, airway ECs produce NO13–15, a
molecule that plays crucial roles in the mechanisms of host
defense16–18. We hypothesized that LPS-induced TRPV4
activation may modulate NO concentration. NO production is
typically evaluated several hours after the LPS challenge, but
considering the fast effects of LPS on TRPV4, we were interested
in a possible NO response during acute LPS stimulation. Thus, we
performed simultaneous measurements of intracellular Ca2+
concentration and NO levels. Application of LPS triggered
increase in intracellular Ca2+ concentration and subsequent NO
production (Fig. 4a, e, f). mTEC derived from Trpv4 KO mice did
not produce NO upon LPS application (Fig. 4b, e, f). In WT
mTEC, inhibition of TRPV4 with HC067047 signiﬁcantly
reduced the increase in intracellular Ca2+ concentration and
the NO production during stimulation with LPS (Fig. 4c, e, f).
In contrast, NO was produced after LPS-induced intracellular Ca2
+ increase in cells isolated from Tlr4 KO mice (Fig. 4d–f).
Stimulation of both WT and Tlr4 KO mTEC with GSK1016790A
also induced an increase of NO (Fig. 4e, f and Supplementary
Fig. 3c, b). The effects of LPS on intracellular Ca2+ and
NO production were recapitulated in human nasal ECs freshly
isolated from inferior turbinate of healthy, non-smoking
individuals (Supplementary Fig. 4a, b). These ﬁndings,
together with the fact that the increase in NO signals occurred
within 1 min after the raise in intracellular Ca2+ concentration,
are indicative of a fast Ca2+-dependent mechanism of NO
production.
NO is mainly produced from the oxidation of arginine by NO
synthases (NOS), a process that requires the presence of Ca2
+/calmodulin coupling to the reductase domain of NOS19. Thus,
we analyzed the presence of NOS isoforms in lysates from mTEC.
We found that mTEC isolated from WT, Tlr4 KO and Trpv4 KO
mice express the neuronal (n) NOS and the inducible (i) NOS
(Fig. 4g). We were unable to detect the endothelial (e) NOS
isoform (Supplementary Fig. 15a).
The fact that the nNOS isoform is directly activated by Ca2
+/CaM binding suggests that this isoform is a major contributor
to the LPS-induced Ca2+-dependent production of NO. None-
theless, the constitutive expression of iNOS prompted us to
determine whether the LPS-induced TRPV4 activation can
regulate iNOS enzymatic activity. To evaluate this, we used a
human bronchial EC line (16HBE), where we found iNOS to be
the only NOS isoform constitutively expressed (Fig. 5a). The vast
majority of these cells (96.5%) were responsive to GSK1016790A
(Fig. 5b), demonstrating a wide functional expression of TRPV4.
Application of 20 µg ml−1 LPS increased the intracellular Ca2+
concentration in 35% of cells (Fig. 5b) and HC067047 prevented
LPS-induced responses in a reversible manner (Supplementary
Fig. 5a). Experiments performed in HEK293T cells further
conﬁrmed that, like for the mouse isoform, LPS activates human
TRPV4 (Supplementary Fig. 5b, c).
As observed in mTEC, the TRPV4-mediated Ca2+ increase
induced by LPS in 16HBE cells was followed by a rapid
production of NO (Fig. 5d, e). Preventing the intracellular Ca2+
increase by inhibiting TRPV4 with HC067047 signiﬁcantly
reduced NO production induced by LPS or GSK1016790A
(Fig. 5d, e). Pre-incubation with the NOS inhibitor Nω-Nitro-L-
arginine methyl ester (L-NAME, 1 mM) strongly reduced NO
production without affecting the TRPV4-mediated intracellular
Ca2+ increase (Supplementary Fig. 6a, b), indicating that NO is
mainly derived from iNOS activation.
We were able to discard other Ca2+ entry pathways as possible
contributors to the LPS-induced NO production. It has been
reported that NO can be generated in skin keratinocytes from
nitrite precursors by changes in intracellular pH induced through
TRPV3-mediated Ca2+ increase20. However, we found TRPV3 to
be very poorly expressed in 16HBE cells (Supplementary Fig. 7a)
and that transfection of this channel in HEK293T cells rendered
these cells sensitive to the TRPV3 agonist camphor, but not to
LPS (Supplementary Fig. 7b). Furthermore, we found that TRPA1
and TRPV1 are not functionally expressed in 16HBE cells
(Supplementary Fig. 7c). We also conﬁrmed that the ubiquitously
expressed Ca2+/Mg2+-permeable channel TRPM7 was not
stimulated by LPS (Supplementary Fig. 7d, e).
Interestingly, iNOS protein levels were not changed during the
immediate response to LPS exposure (Fig. 5c), demonstrating that
the NO production does not involve de novo synthesis of enzymes
but a post-translational regulation. In rat aortic vascular smooth
muscle cells iNOS has been shown to aggregate in inactive pools
and to become functional upon disaggregation induced by
activation of the Ca2+/CaM pathway21. Similarly, we detected
iNOS associated in aggresomes in 16HBE cells (Fig. 5f). Applica-
tion of LPS or GSK1016790A reduced the number of iNOS
aggresomes, an effect that was prevented by inhibition of TRPV4
with HC067047 (Fig. 5f, g). Taken together, these data indicate
that activation of TRPV4 triggers disaggregation of iNOS.
Anti-bacterial effect of TRPV4-mediated NO production. To
evaluate the anti-bacterial effect of EC-derived NO and the pos-
sible implication of TRPV4 we incubated non-pathogenic E. coli
in exponential growing phase (0.1 optical density, OD) with
conﬂuent cultures of mTEC and quantiﬁed the percentage of
dead bacteria using a live/dead (green/red) stain after 2 h. Incu-
bation of bacterial cultures with WT mTEC killed ~ 13% of cells,
whereas exposure to mTEC lacking TRPV4, or to cells pre-
incubated with HC067047 or L-NAME strongly reduced the anti-
bacterial effect (Fig. 6a, b). As control of these experiments we
found that untreated cultures had 1.4± 0.3% dead cells and that
the known bactericidal isopropanol induced 80± 9% cell death
(Supplementary Fig. 8). We corroborated the ability of the 0.1 OD
bacterial culture to induce intracellular Ca2+ signals in TRPV4-
transfected HEK293T cells (Fig. 6c, d). The percentage of
responding cells was reduced in the presence of HC067047 or
upon pre-incubation with PMB (Fig. 6c, d and Supplementary
Fig. 9a, b). This strongly suggests that free LPS present in the
bacterial culture is responsible for TRPV4 activation.
LPS increases ciliary beat frequency. In ciliated ECs, TRPV4-
mediated Ca2+ entry in response to changes in tonicity, ﬂuid
viscosity, or purinergic stimulation is crucial in the regulation of
CBF22–24. Thus, we evaluated the effect of LPS-induced activation
over beating frequency of ciliated mTEC. Application of LPS
increased the CBF in mTEC cells isolated from WT mice, but
failed to induce any effect on Trpv4 KO cells or in WT cells
pre-incubated with HC067047. The increase in CBF by LPS was
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not affected by L-NAME, excluding the implication of NO
(Supplementary Fig. 10).
TRPV4 regulates response to LPS in the airways. To determine
whether TRPV4 is involved in airway responses to LPS in vivo,
we monitored the parameters describing the ventilatory function
of mice using unrestrained whole-body plethysmography and
assessed the numbers of lung-inﬁltrating macrophages and neu-
trophils in bronchoalveolar lavage ﬂuids. We found that none of
these magnitudes were signiﬁcantly different between WT and
Trpv4 KO mice in control condition (Supplementary Fig. 11a–g),
indicating that TRPV4 is not a determinant of the basal venti-
latory function or leukocyte inﬁltration into the airways.
Administration of LPS, but not of control aerosols, signiﬁcantly
altered the ventilatory pattern of WT mice, including an increase
in the enhanced pause (Penh, Fig. 7a and Supplementary Fig. 12a,
b), in agreement with previous studies25, 26. LPS induced sig-
niﬁcantly stronger ventilatory changes (Fig. 7a, d) and cell inﬁl-
tration responses (Fig. 7b, c, e, f) in Trpv4 KO and in WT mice
treated with HC067047. Although LPS induced changes in several
ventilatory parameters, the increase in the time of expiration (Te)
determined most of the difference of the response in Penh
between WT and Trpv4 KO mice (Supplementary Fig. 13a–f).
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Fig. 4 LPS-induced activation of TRPV4 triggers NO production in mTEC. a–d Traces of intracellular Ca2+ signals (black traces) and normalized
ﬂuorescence of the NO-sensitive dye DAF-FM (F/F0, red traces) recorded in mTEC harvested from wild type (a, c), Trpv4 KO (b) and Tlr4 KO (d) mice
(LPS, 20 µg ml−1; HC067047, 10 µM). e, f Average changes in intracellular Ca2+ (e) and NO production (f) induced by LPS in wild type (WT), Trpv4 KO and
Tlr4 KO. In another series of experiments, WT cells were also pre-incubated with the TRPV4 inhibitor HC067047 (HC, 10 µM). The two bars on the right
show the responses to GSK1016790A (GSK, 10 nM) in WT and Tlr4 KO mice. n> 40 per bar; **P< 0.01, Kruskal–Wallis test. g Western blot of mTEC
lysates probed for the iNOS and nNOS isoforms. Non-stimulated splenocytes were used as negative control for NOS expression
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Next, we probed for possible contributions of the major airway
chemosensors TRPA1 and TRPV144–46 in the responses to LPS.
Trpa1/Trpv1 double KO mice exhibited basal ventilatory prop-
erties that were similar to WT mice (Supplementary Fig. 11a–g).
LPS induced a signiﬁcantly larger increase in Penh than in WT
mice (Fig. 7g), but no exacerbated neutrophil inﬁltration (Sup-
plementary Fig. 14a, b). The ventilatory and cellular responses to
LPS were signiﬁcantly higher when TRPV4 was pharmacologi-
cally inhibited in Trpa1/Trpv1-deﬁcient mice (Fig. 7g, and Sup-
plementary Fig. 14a, b). Taken together, these ﬁndings
demonstrate that TRPV4 is a main regulator of acute ventilatory
and innate immune responses in the airways upon LPS challenge.
Finally, in line with the exacerbated neutrophil inﬁltration in
LPS-challenged Trpv4 KO, we found that mTEC derived from
these mice produced signiﬁcantly larger amount of neutrophil
chemotractant Cxcl-1 and interleukin (Il)-6 transcripts when
acutely stimulated with LPS (Fig. 7h). Although LPS induced also
the expression of Cxcl-2, its levels were similar in WT and Trpv4
KO mice.
Discussion
LPS is one of the most potent pathogen-associated signals for the
immune system of vertebrates and it is generally believed to be
detected solely by the TLR4 signaling pathway27. We found that
LPS triggers an immediate response in intracellular Ca2+ in air-
way ECs and that this occurred via a TLR4-independent
mechanism. In addition, we found that TRPC6, a Ca2+-perme-
able channel recently described to be crucial for the
TLR4 signaling pathway in vascular endothelial cells28, is not
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expressed in freshly isolated mTEC nor in the 16HBE cell line.
We show here that, in contrast, LPS activates TRPV4, a channel
that is prominently expressed in airway ECs. LPS elicited currents
with characteristic signatures of activation of TRPV4, including a
reversal potential and a rectiﬁcation pattern similar to those of
currents triggered by the speciﬁc agonist GSK1016790A, and
inhibition by the TRPV4 antagonist HC067047. We found that
TRPV4 responses to LPS were signiﬁcantly smaller and less
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prevalent than those to GSK1016790A, which is consistent with
the fact that the former compound is a weaker channel agonist29.
However, the potency of LPS on TRPV4 (11 µg ml−1) is within
the same range of that previously reported for TRPA1 (~ 3 µg ml
−1)8. Also similar to what we found for TRPA18, the free avail-
ability of the lipidic region of LPS is required for TRPV4 acti-
vation. However, in contrast to TRPA1, TRPV4 is activated by
lamellar-shaped LPS from S. minnesota. Although the precise
molecular mechanism underlying the activation of these channels
by LPS remains elusive, we may speculate that TRPV4 is more
sensitive than TRPA1 to mechanical perturbations induced by
LPS in the plasma membrane. Importantly, the concentrations at
which LPS activates TRPV4 (above 3 µg ml−1) are compatible
with those used in experimental models of LPS-induced airway
inﬂammation (e.g., 250 µg ml−130 and 500 µg ml−131 and very
recently in a study on the protective role of LPS against allergy to
house dust mite, ranging 2–20 µg ml−16). Thus, our ﬁndings are
relevant to current experimental models of endotoxin challenge.
It has been shown that intestinal EC lines secrete cytokines and
chemokines several hours after stimulation with the synthetic
TRPV4 agonist 4αPDD32, and that mouse macrophages release
NO 30min after 4αPDD application33. However, the immediate
cellular consequences of TRPV4 stimulation have received less
attention and the effects of natural agonists of this channel
remain unknown. Given that TRPV4 activation occurs within
seconds of exposure to LPS, we here focused on the acute phase of
the cellular responses, particularly within the ﬁrst few minutes of
LPS challenge. We found that LPS triggers TRPV4-dependent
NO production through the activation of NOS, namely nNOS
and iNOS. Both isoforms have been previously reported to be
expressed in airway ECs34–36, although the direct Ca2+ depen-
dence of nNOS19 suggests this isoform as the major contributor
to the NO production upon TRPV4-induced Ca2+ increase.
Interestingly, nNOS has been recently localized in the proximal
part of the ciliary axoneme36, where TRPV4 expression plays a
role in controlling the beating frequency. We found increased
beating frequency in ciliated mTEC upon LPS challenge. How-
ever, this effect was not dependent of NOS-derived NO. On the
other hand, NO produced by TRPV4 stimulation with LPS
induced a direct anti-bacterial effect, as expected from previous
reports37. Furthermore, NO induces a number of additional
protective responses38, including those we show here that depend
of TRPV4, i.e., regulation of neutrophil inﬁltration (see below)
and bronchodilation.
LPS-induced TRPV4-dependent increase in CBF was com-
parable to that triggered by other stimuli of TRPV4, including
heating and the synthetic chemical agonists 4αPDD24 and
GSK1016790A39. However, our results unveiled the ﬁrst naturally
occurring chemical agonist of TRPV4 inducing an increase in
ciliary movement and suggests that TRPV4 activation by LPS
enhances the clearance of pathogens from the airways.
In parallel with nNOS, cytosolic iNOS activity is upregulated in
response to LPS-induced TRPV4 activation. Our confocal
microscopy images revealed the presence of iNOS in aggresome-
like structures in human airway epithelial 16HBE cells, similar to
those described in rat aortic vascular smooth muscle cells21. Thus,
our data suggests that the increase in intracellular Ca2+ con-
centration that results from LPS-induced activation of
TRPV4 stimulates the release of active iNOS from inactive
aggresomes through the activation of Ca2+-calmodulin kinase II
δ2 (CaMKIIδ2)21. The differential compartmentalization of NOS
isoforms might indicate that NOS-derived NO pools may operate
distinctively. A direct activation of nNOS by the TRPV4-
mediated increase in intracellular Ca2+ concentration can
quickly induce increase in luminal NO levels and increase CBF.
On the other hand, TRPV4-triggered iNOS disaggregation and
consequent activation can reinforce NO diffusion to the lumen of
the airways, but can also contribute to NO diffusion to the basal
layer of the ECs.
Acute inhalation of LPS activates the TLR4 pathway, leading to
changes in the ventilatory pattern and to a severe inﬂammatory
response characterized by activation of alveolar macrophages and
recruitment of polymorphonuclear leukocytes into the airways40–
43. We here present genetic and pharmacological evidence
demonstrating that TRPV4 activation limits the magnitude of
these responses. This key role of TRPV4 is compatible with its
high expression in airway ECs, which are readily accessible to
luminal LPS. Our data also suggest that TRPA1 and TRPV1, two
main receptors of noxious chemicals in the airways44–46, may
contribute to the LPS-induced ventilatory changes, although to a
lesser extent.
The mechanisms underlying the limiting role of TRPV4 in
ventilatory changes and leukocyte inﬁltration into the airways
induced by LPS may be based partly on the TRPV4-dependent
production of NO, discussed above. NO, most likely the pool
produced by iNOS, is known to induce bronchodilation through
its relaxing action on airway smooth muscle47, 48 and to decreased
leukocyte adhesion on endothelial cells49–53 through down-
regulation of cell adhesion molecules54–56. The protective role of
the LPS-TRPV4-iNOS mechanism we unveiled here is in line
with the exacerbated inﬂammatory responses to LPS observed in
Inos-null mice31. Together with the absence of NO, increased
chemotractant levels observed in Trpv4 KO mTEC might be the
responsible for the exacerbated neutrophil inﬁltration upon LPS
challenge.
It has been proposed that inhibition of TRPV4 might be
beneﬁcial for the treatment of multiple respiratory conditions,
including chronic heart failure, hypoxia-induced pulmonary
hypertension, acute lung injury, chronic obstructive pulmonary
disease, and cough45, 57, 58. However, our results demonstrate that
inhibition of this channel abrogates protective responses in mouse
airway ECs and exacerbates mouse ventilatory and inﬂammatory
responses to LPS challenge. Furthermore, we found that the
TRPV4-mediated intracellular Ca2+ increase and subsequent NO
production in response to LPS operates also in freshly isolated
human nasal ECs. This argues for the need of therapies excluding
the inhibition of this channel in airway ECs, especially in con-
ditions that may be associated with respiratory infections with
gram-negative bacteria.
In summary, our work shows that LPS activates TRPV4 and
that this triggers immediate protective responses in airway ECs,
unveiling this channel as a player in innate defense responses.
Table 1 List of TaqMan probes
Gene name Probe ID (in Applied Biosytems)
Trpc6 Mm01176083_m1
Trpa1 Mm00625268_m1
Trpv1 Mm01246302_m1
Trpv2 Mm00449223_m1
Trpv3 Mm00454996_m1
Trpv4 Mm00499025_m1
Trpv5 Mm01166037_m1
Trpv6 Mm00499069_m1
Trpm3 Mm00616485_m1
Trpm7 Mm00457998_m1
Trpm8 Mm00454566_m1
Il-6 Mm00446190_m1
Cxcl-1 Mm04207460_m1
Cxcl-2 Mm00436450_m1
β-actin 4352341E
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Our ﬁndings demonstrate that, not only sensory neurons, but also
non-excitable cells are endowed with TRP channel-mediated
mechanisms of detection of major bacterial cues. These
mechanisms trigger very fast, cell-intrinsic events, distinct from
the currently established ones based on cytokine secretion reg-
ulating the homing and activation of immune cells.
Methods
Transfections. For intracellular Ca2+ imaging experiments, HEK293T (from
American Type Culture Collection) cells were transiently transfected with the
mouse TRPV4, in the bicistronic pCAGGS/IRES-GFP vector, using the Mirus
TransIT-293 kit (Sopachem n.v./s.a, Eke, Belgium).
Intracellular Ca2+ and nitric oxide imaging experiments. Cells were incubated
with Fura-2 acetoxymethyl ester for 30 min at 37 °C. For recordings, bath solutions
prepared in Krebs (containing (in mM): 150 NaCl, 6 KCl, 1.5 CaCl2, 1 MgCl2, and
10 HEPES, 10 glucose and titrated to 7.4 with NaOH) were perfused by gravity via
a multi—barreled pipette tip. Intracellular Ca2+ concentration was monitored
through the ratio of ﬂuorescence measured upon alternating illumination at 340
and 380 nm using an MT-10 illumination system and the Xcellence pro software
(Olympus Belgium N.V., Berchem, Belgium). The TRPV4 inhibitor HC067047 (10
µM) was perfused prior to LPS applications, as indicated in the Figures. The TLR4
inhibitor Cli-095 (1 µM) was added to the cells 20 min before measurements, and
constant perfusion of this compound was kept during the measurements. PMB
(300 µg ml−1) was added to LPS solutions and mixed for 30 min.
For simultaneous Ca2+ and NO imaging, cells were incubated with Fura-2
acetoxymethyl ester as detailed above and were also pre-loaded with 4-Amino-5-
Methylamino-2',7'-Diﬂuoroﬂuorescein (DAF-FM) diacetate for 20 min. DAF-FM
images were acquired using the excitation/emission wavelengths at ~488/520 nm.
The ﬂuorescence intensity of individual cells in each experiment is expressed as
percentage of the average signal recorded at baseline (F/F0, %).
Patch-clamp. The whole-cell patch-clamp recordings were made using an EPC-7
patch-clamp ampliﬁer (HEKA, Lambrecht/Pfalz, Germany) and the Clampex
9.0 software program (Axon instruments, Sunnyvale, CA, USA). Currents were
ﬁltered at 5 kHz, acquired at 10 kHz, and stored for off-line analysis on a personal
computer. In order to minimize voltage errors, the series resistance was compen-
sated by 30–50% and the capacitance artifact was reduced using the ampliﬁer
circuitry. Membrane TRPV4 currents were elicited by a 400 ms-long voltage ramp
from −125 mV to + 100 mV every 5 s. Before recordings, cells were allowed to
stabilize in Krebs solution. During recordings cells were perfused with extracellular
solution (in mM): 140 NaCl; 5 CsCl; 2 CaCl2; 1 MgCl2; 10 HEPES, 10 glucose
monohydrate and pH adjusted to 7.4 with NaOH). The pipette solution contained
(in mM): 110 cesium methane sulfonate; 25 CsCl; 30 HEPES; 0.362 CaCl2; 2 MgCl2
and pH adjusted to 7.2 with CsOH.
Ca2+ imaging and ciliary beat frequency in mTEC. Tracheobronchial ECs
(containing ciliated cells) were isolated from WT and Trpv4 KO mouse trachea and
cultured following the protocol described elsewhere24, 59. Brieﬂy, trachea are dis-
sected, opened lengthwise and placed onto 0.15% pronase solution for overnight
digestion. Next day, cells are collected by gentle rocking of the pronase solution,
and transferred to 20% FBS Ham-F12 medium. After centrifugation at 1400 rpm,
10 min at 4 °C, cells are rinsed in DMEM/F12 supplemented with penicillin/
streptomycin, HEPES (15 mM), glutamine (4 mM), and 0.0375% NaHCO3 (mTEC
Basic medium) and cultured for 5 h in Primaria Plates (Thermo Fisher Scientiﬁc,
Rockford, IL, USA). Dishes are gently rinsed with mTEC Basic medium and cells
are collected and centrifuged at 1400 rpm, 10 min at 4 °C. After centrifugation, cells
are resuspended in 5% FBS mTEC Basic Medium supplemented with insulin (20
µg ml−1), epidermal growth factor (40 ng ml−1), bovine pituitary extract
(60 µg ml−1), transferrin (5 µg ml−1), cholera toxin (100 ng ml−1), and retinoic acid
(0.1 µM), and seeded in new culture plates. ECs are used after 2 days in culture.
For Ca2+ imaging experiments and NO measurements, isolated cells were
seeded in glass coverslips pre-coated with collagen I. CBF was measured in primary
cultures ciliated cells using with a high-speed digital imaging system as previously
described24. Brieﬂy, phase-contrast images (512 × 512 pixels) were collected at
120–135 frames per second with a high-speed CCD camera using a frame grabber
(Infaimon, Barcelona, Spain) and recording software from Video Savant (IO
Industries, London, ON, Canada). The CBF was determined from the frequency of
variation in light intensity of the image as a result of repetitive motion of cilia.
Bacterial live-dead assay. Bacterial live-dead assay was adapted from a protocol
described by Lee and colleagues11. Overnight cultures of Escherichia coli (DH5α)
were diluted in LB medium (in g L−1: 10 Tryptone; 5 yeast extract; 10 NaCl) and
grown to log phase (OD= 0.1, ∼1 h). Bacteria (1 ml) were resuspended in low-salt
(50%) saline supplemented with 0.5 mM glucose, 1 mM HEPES and 1.5 mM CaCl2
(pH 7.4) and incubated with shaking for 60 min. Bacteria in 200 μl of this solution
were added to mTEC cells previously grown to conﬂuence in 12-well plates. Where
indicated, epithelial cultures were pre-incubated for 15 min with the TRPV4
inhibitor HC067047 (1 μM) or the NOS inhibitor L-NAME (1mM). Bacteria were
allowed to settle for 10 min and 100 μl of solution were carefully removed. After
incubation for 2 h at 37 °C, bacteria were collected in 1 ml of supplemented saline
and centrifuged at 5000 rpm for 5 min. Bacteria pellets were later resuspended in
30 μl of a 1:1 solution of SYTO 9 and propidium iodide (PI) (LIVE/DEAD Bac-
Light Bacterial Viability Kit; Invitrogen, Merelbeke, Belgium). This 1:1 mixed
solution allowed identifying dead cells as red, whereas all cells (living and dead
cells) were stained in green. Cells were mounted in glass slides and visualized using
an Olympus microscope. At least 5 randomly selected ﬁelds per condition were
imaged. Stainings were quantiﬁed by determining the area of positive red and green
ﬂuorescence for each image using a custom-made routine in Matlab (The Math-
Works, Inc., MA, USA). Since SYTO9 stains both living and dead bacteria, we
calculated the percentage of dead cells as Area_PI/Area_SYTO9. Control experi-
ments for dead bacteria were performed by incubating 0.1 OD bacterial culture in
isopropanol for 30 min. Simultaneously, 0.1 OD bacteria were kept in saline
solution to assess spontaneous cell death.
Western blot. Freshly isolated splenocytes, freshly isolated mouse airway ECs and
16HBE cells (kindly provided by Dr. Gruenert, University of California, San
Francisco, USA) were lysed in ice for 30 min using fresh prepared lysis buffer
containing: 150 mM NaCl, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1%
SDS, 50 mM Tris, pH 8.0, supplemented with protease inhibitor cocktail (Westburg
BV, Leusden, The Netherlands). Proteins were collected from the supernatant after
centrifugation and protein concentration was determined with the bicinchoninic
acid protein assay kit (Thermo Scientiﬁc, Waltham, MA, USA). Equal protein
amounts (20 µg) were resolved on precast NuPAGE gels (Invitrogen) and trans-
ferred to polyvinylidine diﬂuoride membranes. Membranes were further probed
with iNOS (1:1000; #2977), nNOS (1:1000; #4234), eNOS (1:1000; clone 49G3,
#9586) and β-actin (1:10,000; clone AC-15, Sigma-Aldrich) speciﬁc antibodies.
Anti-mouse (1:10,000; #7076) or anti-rabbit (1:10,000; #7074) secondary antibodies
were incubated for 1 h at room temperature. Signals were visualized by enhanced
chemiluminescence according to the manufacturers’ instructions (ECL kit, Invi-
trogen). Antibodies against NOS isoforms and secondary antibodies were pur-
chased from Cell Signaling Technology (Leiden, Netherlands). Original scans of
probed membranes are shown in Supplementary Fig. 15.
Confocal microscopy. 16HBE cells were seeded in glass coverslips and exposed to
LPS or to the TRPV4 agonist GSK1016790A during 5 min. When indicated, cells
were pre-incubated for 15 min with the TRPV4 inhibitor HC067047 (10 µM). After
treatment, cells were ﬁxed with cold paraformaldehyde and permeabilized with
0.2% Triton X-100. Primary antibody against iNOS (1:1000; PA3-030A, Thermo-
Fisher Scientiﬁc) was incubated overnight at 4 °C, followed by anti-rabbit Alexa
Fluor Plus 488 (1:1000; A32731, Invitrogen) for 1 h at room temperature. Cover-
slips were mounted in glass slides using DAPI-containing mounting solution
(VectaShield, Vector Laboratories, Burlingame, CA, USA). The confocal images of
labeled cells were collected using the optimal pinhole size for the ×63 oil objective
of a Zeiss LSM 510 Meta Multiphoton microscope (Carl Zeiss AG, Oberkochen,
Germany). We used a custom-designed software in Matlab (The MathWorks, Inc)
to determine the number and size of iNOS aggresomes.
Isolation and culture of human nasal epithelial cells. Nasal ECs (NEC) were
isolated from the inferior turbinates of control subjects as previously reported60.
Control subjects were non-smokers, asymptomatic for allergic rhinitis or rhinosi-
nusitis. Detailed subject information can be found in Steelant et al. (2016)61.
Brieﬂy, tissue was washed in sterile saline and enzymatically digested in 0.1%
Pronase (Protease XIV, Sigma) solution in DMEM/F12 medium containing 100 U
mL−1 penicillin, 100 μg ml−1 streptomycin, and 2% Ultroser G (Pall Life Sciences,
Zaventem, Belgium). After overnight digestion at 4 °C, cells were washed and
centrifuged at 100×g for 5 min. Pelleted cells were resuspended in 10 ml of culture
medium and incubated in a plastic culture ﬂask for 1 h at 37 °C to remove ﬁbro-
blasts. NECs in suspension were further puriﬁed by negative selection with CD45
and CD15 magnetic beads (Dynabeads; Invitrogen), according to the manu-
facturer’s instructions. NECs (2 × 105) were plated in 50 μg ml−1 collagen-coated
glass coverslips and used for experiments after 48 h in culture.
Whole-body plethysmography. The ventilatory function of mice was monitored
using unrestrained whole-body plethysmography (EMKA Technologies, Paris,
France). LPS was delivered using a PARI BOY nebulizer (PARI GmbH, Starnberg,
Germany) for 15 min. After recording, mice were deeply anesthetized by intra-
peritoneal injection of pentobarbital and the lungs were washed three times with
sterile 0.9% NaCl solution. Cells recovered from lung lavages were counted and
spun onto microscope slides, air-dried, and stained. For each sample we deter-
mined the number of macrophages, eosinophils, neutrophils, and lymphocytes. To
test the effects of the TRPV4 inhibitor HC067047 this compound was injected intra
peritoneal (vehicle HBSS + 0.8% DMSO) 15 min before the experiments. Lung
lavages and cell counting were performed by different researchers, both blinded to
mouse genotypes.
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RT-PCR. Total RNA from cultured mTEC was extracted using the RNeasy Mini
Kit (Qiagen, Antwerp, Belgium), following manufacturer’s protocol. RNA con-
centration was assessed using a NanoDrop ND 1000 Spectrophotometer (Nano-
Drop Technologies, Wilmington, DE, US). cDNA synthesis was performed with 1
µg of total RNA using the Ready-To-Go You-Prime First-Strand Beads (GE
Healthcare, Diegem, Belgium). Quantitative PCR reactions (20 μl), containing 3 μl
cDNA template (diluted 1:5), Universal TaqMan MasterMix (2x concentrated, Life
Technologies), speciﬁc TaqMan probes (Table 1, 20x concentrated, Life Technol-
ogies) and H2O, were performed with the 7500 Fast Real-Time PCR System (Life
Technologies). Reactions were made using the following program: 50 °C for 2 min
and 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 sec and 60 °C for 1 min.
Non-template controls (NTCs) were used as negative controls in every experiment.
For cytokine expression experiment, mTEC from WT and Trpv4 KO mice were
incubated with LPS (20 µg ml−1) during 3 h prior to RNA isolation protocol.
Animals. Ten- to 12-week-old male mice were used in all experiments. WT C57Bl/
6 mice were obtained from Janvier (France). Trpv4 KO mice and Tlr4 KO mice
were kindly provided by Prof. W. Liedtke (Duke University, Durham, NC, USA)
and by Profs. B. Lambrecht and H. Hammad (VIB, Ghent, Belgium). Trpa1/Trpv1
double KO mice were obtained from an in-house breeding program. All knockout
mice were backcrossed at least 10 times in the C57Bl/6 background. Mice were
housed under identical conditions, with a maximum of four animals per cage on a
12-h light–dark cycle and with food and water ad libitum. All animal experiments
were carried out in accordance with the European Union Community Council
guidelines and were approved by the local ethics committees.
Reagents. All chemicals were purchased from Sigma-Aldrich (Bornem, Belgium).
We used LPS extracted from E. coli, strain 0127:B8.
Statistics. Magnitudes were statistically compared using GraphPad Prism v.5
(GraphPad Software) as indicated in Figure legends. Differences were considered to
be statistically signiﬁcant when P < 0.05. Normality was not checked prior para-
metric tests. However, when parametric test were used, non-parametric tests were
carried out in parallel on data sets yielding the same conclusions. No statistical
method was used to predetermine sample sizes. Nonetheless, our sample sizes are
similar to those used in generally used in the ﬁeld. The variance was generally
similar among compared groups. No blinding/randomization was performed.
Data availability. All relevant data from this article are available from the authors
upon reasonable request.
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